Indian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...

A gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...

The poll of 3,644 respondents, conducted between June 17 and 20 by the Hebrew University of Jerusalem in collaboration with the Agam Instit...

A groundbreaking minimally invasive procedure, knee embolization, is offering new hope for knee osteoarthritis sufferers. Developed by Colu...

Cancer Weekly Horoscope (20th June 2026 to 26th June 2026): Cancer, this week marks the beginning of a powerful personal cycle as the Sun e...

Alembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...

Pfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...

Jeremy Clarkson has revealed his diagnosis with an aggressive form of prostate cancer, detected last summer and treated with surgery. Prost...

Benjamin Netanyahu's grip on power is weakening. Facing corruption charges and criticism over security lapses, he now confronts voters' jud...

Former US President Donald Trump has publicly criticized Israeli Prime Minister Benjamin Netanyahu. Trump claims credit for Israel's existe...

Israel's Prime Minister Benjamin Netanyahu faces a clash with U.S. President Donald Trump over a new interim deal with Iran. Israel feels t...

Novartis India has launched Pluvicto, the nation's first approved radioligand therapy for eligible prostate cancer patients. This precision...

With an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...

AstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...

Precision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...

The study, which followed patients for over five years, found that those ⁠who received ⁠the regimen were nine times more likely to have lit...

Novartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...